This is the authors' abstract. We don't add key points for this paper.
Sir Ashley Miles has admirably surveyed how the knowledge of the plasma kinin forming system developed and where it has arrived at the present time. I shall discuss some biochemical and functional details of this process. Many of these details are still incomplete, or at least controversial, and I shall present work dealing with such questions, partly because I believe that the methods employed may be useful in the study of other proteolytic systems in plasma, and partly because the results offer opportunities of comparing the enzymes in the different systems. Activation of factor X II The intrinsic plasma kinin forming system is—like the clotting and fibrinolytic systems—an enzymic cascade. The intrinsic versions of all three cascades share in my view a common initial step, namely the activation of clotting factor XII. The first clue that a plasma constituent responsive to glass was concerned with intrinsic plasma kinin formation, was provided by the finding of Armstrong, Jepson, Keele & Stewart (1954) that on exposure to glass human plasma forms a peptide which produces pain on the bare cantharidin blister base. Later, after factor XII had been identified by Ratnoff & Colopy (1955), Margolis (1957, 1958), working in Macfarlane’s and Keele’s departments, established that this response was initiated by the adsorption and activation of factor XII by the glass surface. The development of measurable activity on vascular permeability was also dependent on the activation of this factor (Miles 1964). Eisen & Keele (i960) then found that dilution, treatment with acetone, or acidification did not induce normal kinin formation in plasma lacking factor XII (Hageman trait plasma), which implied that these modes of activation also required factor XII. Now, these procedures are effective even when plasma is exposed to so-called ‘inert' surfaces like silicone or polythene. However, it now seems that all these procedures act only by removing factors opposing kinin formation, and that the activation of factor XII is still due to surfaces—even if these are the most inert surfaces at our disposal. This became apparent in work with the antiheparin agent hexadimethrine bromide which abolishes the capacity of surfaces to activate factor XII (Eisen 1964). The only known activation of factor XII which is not a surface reaction, seems to be activation by ellagic acid (4,4',5,5',6,6'-hexahydroxydiphenic acid 2,6:2',6'-dilactone; Ratnoff & Crum 1964).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
V. Eisen (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: